Health
Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials
During the October Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and portfolio director Jeff Marks’ responses. Their answers have been edited for clarity. 1. Why do rising interest rates have such a negative effect on technology stocks? (Rod) Jim Cramer: When the Federal Reserve started raising rates, […]
Read More
Here’s a rapid-fire update on all 36 stocks in our portfolio, including our latest addition
Jim Cramer ran through the names during the Club’s October Monthly Meeting on Wednesday. Source
Read More
Jim Cramer praises Walgreens new CEO pick, says buy the stock ‘perhaps aggressively’
CNBC’s Jim Cramer on Wednesday praised the incoming CEO of Walgreens Boots Alliance, saying industry veteran Tim Wentworth is the right choice to lead the struggling pharmacy chain in its transition to offering more health-care services. “This guy is the real deal. I just salute him and think he can take you to a higher […]
Read More
Period care brands August, Rael and others form coalition to fight the ‘tampon tax,’ reimburse consumers
Starting Wednesday, consumers paying state sales tax on menstrual products will be able to get those costs on some period care purchases reimbursed. The Tampon Tax Back Coalition — an initiative of period care brands August, Cora, LOLA, The Honey Pot, Rael, Here We Flo, Saalt and DIVA — will reimburse consumers for the tax […]
Read More
Walgreens names veteran health-care executive Tim Wentworth as next CEO
A Walgreens sign is displayed on the window of one of its stores in Hollywood, California, on March 9, 2023. Stefani Reynolds | AFP | Getty Images Walgreens Boots Alliance has chosen veteran health care executive Tim Wentworth as the company’s new chief executive. Wentworth is the former CEO of the nation’s largest pharmacy benefits […]
Read More
15 stocks with a history of dividend growth are expected to deliver once again this year
Broadcom (AVGO), Caterpillar (CAT) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue in their current fiscal years. Long-term investors should look to own companies with a history of dividend growth instead of chasing stocks with high yields, Morgan Stanley strategists […]
Read More
Microsoft announces new AI tools to help doctors deliver better care
Microsoft CEO Satya Nadella listens to an audience member’s question during the company’s annual shareholder meeting in Bellevue, Washington, Nov. 30, 2016. Stephen Brashear | Getty Images News | Getty Images Microsoft on Tuesday announced new data and artificial intelligence products that aim to help health-care organizations easily access and learn from the mountains of […]
Read More
This animal health stock could gain nearly 30% as it ramps up sales of dog arthritis treatment
Zoetis shares have fallen about 10% since their recent peak in late July amid concerns that a weakening economy will prompt consumers to spend less on their pets. But investors may be overlooking the opportunity from a key product launch that could become one of the biggest in animal health history. A recent survey conducted […]
Read More
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy. The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss. Their skyrocketing popularity has boosted Novo Nordisk to new heights. Novo Nordisk’s […]
Read More
Supreme Court declines to hear case challenging FDA authority to reject flavored e-cigarettes
A woman smokes an E-Cigarette at Digital Ciggz in San Rafael, California. Justin Sullivan | Getty Images The Supreme Court on Tuesday declined to hear arguments in a case challenging the Food and Drug Administration’s authority to reject approvals of flavored electronic cigarettes. The case is one of several challenges to the FDA’s regulation of […]
Read More